Literature DB >> 21052012

MicroRNAs in vascular disease.

Shanshan Qin1, Chunxiang Zhang.   

Abstract

MicroRNAs (miRNAs) are a novel class of endogenous, small, noncoding RNAs that regulate gene expression via degradation, translational inhibition, or translational activation of their target messenger RNAs. Functionally, an individual miRNA is important as a transcription factor because it is able to regulate the expression of its multiple target genes. As a group, miRNAs are able to directly regulate at least 30% of genes in a cell. In addition, other genes may also be regulated indirectly by miRNAs. It is therefore not surprising that miRNAs could be the pivotal regulators in normal development, physiology, and pathology. Recent studies have identified that miRNAs are highly expressed in vasculature and their expression is dysregulated in diseased vessels. miRNAs are found to be critical modulators for vascular cell functions such as cell differentiation, contraction, migration, proliferation, and apoptosis. Accordingly, miRNAs are involved in the vascular dysfunction, ischemic angiogenesis, reendothelialization, and vascular neointimal lesion formation under diverse vascular diseases. miRNAs may serve as novel therapeutic targets for vascular diseases such as impaired angiogenesis or reendothelialization, restenosis, atherosclerosis, hypertension, and diabetic vascular complication. This review article summarizes the research progress regarding the roles of miRNAs in vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21052012      PMCID: PMC4517184          DOI: 10.1097/FJC.0b013e318203759b

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  48 in total

1.  MicroRNAs modulate the angiogenic properties of HUVECs.

Authors:  Laura Poliseno; Andrea Tuccoli; Laura Mariani; Monica Evangelista; Lorenzo Citti; Keith Woods; Alberto Mercatanti; Scott Hammond; Giuseppe Rainaldi
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

Review 2.  The evolution of gene regulation by transcription factors and microRNAs.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

3.  Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.

Authors:  Angelika Kuehbacher; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2007-05-31       Impact factor: 17.367

Review 4.  Vascular repair by endothelial progenitor cells.

Authors:  Anna Zampetaki; John Paul Kirton; Qingbo Xu
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

Review 5.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

6.  A translational study of circulating cell-free microRNA-1 in acute myocardial infarction.

Authors:  Yunhui Cheng; Ning Tan; Jian Yang; Xiaojun Liu; Xiaopei Cao; Pengcheng He; Xiaoli Dong; Shanshan Qin; Chunxiang Zhang
Journal:  Clin Sci (Lond)       Date:  2010-04-20       Impact factor: 6.124

7.  Plasma miR-208 as a biomarker of myocardial injury.

Authors:  Xu Ji; Rie Takahashi; Yumiko Hiura; Go Hirokawa; Yasue Fukushima; Naoharu Iwai
Journal:  Clin Chem       Date:  2009-08-20       Impact factor: 8.327

8.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

9.  MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression.

Authors:  Chia-Hui Wang; Daniel Y Lee; Zhaoqun Deng; Zina Jeyapalan; Shao-Chen Lee; Shireen Kahai; Wei-Yang Lu; Yaou Zhang; Burton B Yang
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

10.  Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

Authors:  Coen van Solingen; Leonard Seghers; Roel Bijkerk; Jacques M G J Duijs; Marko K Roeten; Annemarie M van Oeveren-Rietdijk; Hans J Baelde; Matthieu Monge; Joost B Vos; Hetty C de Boer; Paul H A Quax; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

View more
  32 in total

1.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

2.  Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction.

Authors:  Jeffrey A Jones; Robert E Stroud; Elizabeth C O'Quinn; Laurel E Black; Jeremy L Barth; John A Elefteriades; Joseph E Bavaria; Joseph H Gorman; Robert C Gorman; Francis G Spinale; John S Ikonomidis
Journal:  Circ Cardiovasc Genet       Date:  2011-10-18

3.  Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice.

Authors:  Marpadga A Reddy; Wen Jin; Louisa Villeneuve; Mei Wang; Linda Lanting; Ivan Todorov; Mitsuo Kato; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-12       Impact factor: 8.311

4.  Role of MiR-126a-3p in Endothelial Injury in Endotoxic Mice.

Authors:  Maoping Chu; Shanshan Qin; Rongzhou Wu; Xiangyu Zhou; Xiaojun Tang; Shuo Zhang; Qifeng Zhao; Huating Wang; Ying Liu; Xiaohua Han; Jian Xiao; Xiaokun Li; Chunxiang Zhang
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

Review 5.  Neurogenic hypertension: revelations from genome-wide gene expression profiling.

Authors:  Francine Z Marques; Brian J Morris
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

6.  MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2.

Authors:  Xiaojun Liu; Yunhui Cheng; Xiuwei Chen; Jian Yang; Ling Xu; Chunxiang Zhang
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 7.  Exercise training in hypertension: Role of microRNAs.

Authors:  Vander José das Neves; Tiago Fernandes; Fernanda Roberta Roque; Ursula Paula Renó Soci; Stéphano Freitas Soares Melo; Edilamar Menezes de Oliveira
Journal:  World J Cardiol       Date:  2014-08-26

Review 8.  Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis.

Authors:  Johnathan Kawika Cooper; Rochell Issa; Pratyush Pavan Devarasetty; Rachel M Golonka; Veda Gokula; Joshua Busken; Jasenka Zubcevic; Jennifer Hill; Matam Vijay-Kumar; Bindu Menon; Bina Joe
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

Review 9.  Roles of microRNAs in atherosclerosis and restenosis.

Authors:  Li-Jing Chen; Seh Hong Lim; Yi-Ting Yeh; Sheng-Chieh Lien; Jeng-Jiann Chiu
Journal:  J Biomed Sci       Date:  2012-08-29       Impact factor: 8.410

10.  Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction.

Authors:  Guangwen Long; Feng Wang; Quanlu Duan; Shenglan Yang; Fuqiong Chen; Wei Gong; Xu Yang; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.